✦ LIBER ✦

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

✍ Scribed by Dr Harry C. S. Howlett, Clifford J. Bailey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Assessment of Exenatide in

✍ Professor Dr Baptist Gallwitz 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 324 KB

Cardiovascular risk assessment in type 2

✍ Ebaa Al-Ozairi; R. Jan-Willem Middelbeek; Edward S. Horton 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 85 KB

The assessment of cardiovascular risk in

✍ Hancu, N.; Cerghizan, Anca 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Diabetes: Exercise benefits in type 2 di

✍ Barengo, Noël C.; Tuomilehto, Jaakko 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 154 KB

Benefits of acarbose and metformin in ty

✍ Charles Bankhead 📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 295 KB

Metformin: cardiac benefits in obese typ

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB